S. Tunç Et Al. , "Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders," Psychiatry and Clinical Psychopharmacology , vol.29, no.2, pp.123-129, 2019
Tunç, S. Et Al. 2019. Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders. Psychiatry and Clinical Psychopharmacology , vol.29, no.2 , 123-129.
Tunç, S., ATAGÜN, M. İ., NEŞELİOĞLU, S., Bilgin, Y. Y., Başbuğ, H. S., & EREL, Ö., (2019). Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders. Psychiatry and Clinical Psychopharmacology , vol.29, no.2, 123-129.
Tunç, Serhat Et Al. "Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders," Psychiatry and Clinical Psychopharmacology , vol.29, no.2, 123-129, 2019
Tunç, Serhat Et Al. "Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders." Psychiatry and Clinical Psychopharmacology , vol.29, no.2, pp.123-129, 2019
Tunç, S. Et Al. (2019) . "Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders." Psychiatry and Clinical Psychopharmacology , vol.29, no.2, pp.123-129.
@article{article, author={Serhat Tunç Et Al. }, title={Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders}, journal={Psychiatry and Clinical Psychopharmacology}, year=2019, pages={123-129} }